Advances in pediatric antimicrobial agents development

被引:3
|
作者
Wood, James B. [1 ]
Cravens, Lauryn B. [2 ]
Creech, C. Buddy [2 ]
机构
[1] Indiana Univ Sch Med, Div Pediat Infect Dis, Indianapolis, IN 46202 USA
[2] Vanderbilt Univ, Sch Med, Vanderbilt Vaccine Res Program, CCC 5319 Med Ctr North,1161 21st Ave South, Nashville, TN 37232 USA
关键词
antimicrobials; drug development; multidrug-resistant organisms; PLEUROMUTILIN ANTIBIOTIC BC-3781; ACUTE BACTERIAL SKIN; DOUBLE-BLIND; CEFTAZIDIME-AVIBACTAM; TRACT-INFECTIONS; IN-VITRO; SAFETY; CEFTAROLINE; PHASE-3; PHARMACOKINETICS;
D O I
10.1097/MOP.0000000000000713
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Purpose of review Rising rates of multidrug-resistant organisms has necessitated the development of novel antimicrobials. In this review, we will highlight agents that have recently received licensure and those that are in clinical development. Recent findings In recent years, development of novel antimicrobial agents has accelerated. Although most studies have targeted the adult population, studies in pediatric patients are underway. Adequately powered clinical trials are needed to establish the safety and role of these new drugs. Summary The recent development of novel antimicrobials to combat multidrug-resistant organisms is encouraging; however, more studies in the pediatric population are needed.
引用
收藏
页码:135 / 143
页数:9
相关论文
共 50 条
  • [21] Rediscovery of antimicrobial peptides as therapeutic agents
    Ryu, Minkyung
    Park, Jaeyeong
    Yeom, Ji-Hyun
    Joo, Minju
    Lee, Kangseok
    JOURNAL OF MICROBIOLOGY, 2021, 59 (02) : 113 - 123
  • [22] Tau Protein Aggregation in Alzheimer's Disease: Recent Advances in the Development of Novel Therapeutic Agents
    Monteiro, Kadja L. C.
    Alcantara, Marcone G. dos S.
    de Aquino, Thiago M.
    da Silva-Junior, Edeildo F.
    CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (15) : 1682 - 1692
  • [23] New Perspectives on Antimicrobial Agents: Maribavir
    Halpern-Cohen, Virginie
    Blumberg, Emily A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (09)
  • [24] Development of Antimicrobial Defined Daily Dose (DDD) for the Pediatric Population
    Montecatine-Alonso, Elena
    Mejias-Trueba, Marta
    Alfredo Goycochea-Valdivia, Walter
    Chavarri-Gil, Estibaliz
    Fernandez-Llamazares, Cecilia M.
    Dolz, Elisenda
    Maria Gutierrez-Urbon, Jose
    Gallego-Fernandez, Carmen
    Llorente-Gutierrez, Jesus
    Victoria Gil-Navarro, Maria
    ANTIBIOTICS-BASEL, 2023, 12 (02):
  • [25] Recent Advances in the Development of Antimicrobial and Antifouling Biocompatible Materials for Dental Applications
    Ramburrun, Poornima
    Pringle, Nadine A.
    Dube, Admire
    Adam, Razia Z.
    D'Souza, Sarah
    Aucamp, Marique
    MATERIALS, 2021, 14 (12)
  • [26] Recent Advances in the Development and Antimicrobial Applications of Metal-Phenolic Networks
    Li, Yue
    Miao, Yong
    Yang, Lunan
    Zhao, Yitao
    Wu, Keke
    Lu, Zhihui
    Hu, Zhiqi
    Guo, Jinshan
    ADVANCED SCIENCE, 2022, 9 (27)
  • [27] Drug Formulation for Pediatric Oral Antimicrobial Agents in Japan: Current Status, Prospects, and Challenges
    Saito, Jumpei
    Shoji, Kensuke
    Miyairi, Isao
    Yamatani, Akimasa
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2023, 42 (08) : E298 - E303
  • [28] Insight Into the Recent Advances in the Development of Antimicrobial Edible Films for Food Packaging
    Mehmood, Arif
    Aziz, Tariq
    Al-Asmari, Fahad
    Shami, Ashwag
    Haiying, Cui
    Xu, Jinlong
    Lin, Lin
    PACKAGING TECHNOLOGY AND SCIENCE, 2025,
  • [29] Pharmacokinetics/Pharmacodynamics models of veterinary antimicrobial agents
    Luo, Wanhe
    Chen, Dongmei
    Wu, Mengru
    Li, Zhenxia
    Tao, Yanfei
    Liu, Qianying
    Pan, Yuanhu
    Qu, Wei
    Yuan, Zonghui
    Xie, Shuyu
    JOURNAL OF VETERINARY SCIENCE, 2019, 20 (05)
  • [30] Antimicrobial Nano-Agents: The Copper Age
    Ermini, Maria Laura
    Voliani, Valerio
    ACS NANO, 2021, 15 (04) : 6008 - 6029